Position in ABUS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,234,401
+$99,686 QoQ
Shares Held
257,167
+2.0% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Carrera Capital Advisors holds $2,954,652 across 3 Biotechnology names. ABUS ranks #1 (41.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABUS |
Arbutus Biopharma Corp
This page
|
257,167 | $1,234,401 | |
| 2 | ARDX |
Ardelyx, Inc.
|
195,159 | $995,310 | |
| 3 | 137,560 | $724,941 |
All Filings in ABUS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,234,401 | 257,167 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,134,715 | 252,159 | Shares | Sole | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||